Clinical applications of circulating tumor cells in patients with solid tumors
Authors:
Open Access
- 28 January 2024
- journal article
- review article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 41 (4) , 403-411
Abstract
The concept of liquid biopsy analysis has been established more than a decade ago. Since the establishment of the term, tremendous advances have been achieved and plenty of methods as well as analytes have been investigated in basic research as well in clinical trials. Liquid biopsy refers to a body fluid-based biopsy that is minimal-invasive, and most importantly, allows dense monitoring of tumor responses by sequential blood sampling. Blood is the most important analyte for liquid biopsy analyses, providing an easily accessible source for a plethora of cells, cell-derived products, free nucleic acids, proteins as well as vesicles. More than 12,000 publications are listed in PubMed as of today including the term liquid biopsy. In this manuscript, we critically review the current implications of liquid biopsy, with special focus on circulating tumor cells, and describe the hurdles that need to be addressed before liquid biopsy can be implemented in clinical standard of care guidelines.Keywords
Funding Information
- Universitätsklinikum Hamburg-Eppendorf (UKE)
This publication has 85 references indexed in Scilit:
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancerNature Medicine, 2014
- Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2014
- Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create MetastasisCancers, 2013
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast CancerClinical Cancer Research, 2012
- EPISPOT Assay: Detection of Viable DTCs/CTCs in Solid Tumor Patients2012
- Circulating tumour cells in cancer patients: challenges and perspectivesTrends in Molecular Medicine, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- A Pooled Analysis of Bone Marrow Micrometastasis in Breast CancerNew England Journal of Medicine, 2005
- Circulating Tumor Cells in Patients with Breast Cancer DormancyClinical Cancer Research, 2004
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI: Journal of the National Cancer Institute, 1993